-
公开(公告)号:US10780081B2
公开(公告)日:2020-09-22
申请号:US15741871
申请日:2017-06-09
Applicant: ORYZON GENOMICS, S.A.
Inventor: Tamara Maes , Cristina Mascarò Crusat , David Rotllant Pozo
IPC: A61K31/4245 , A61P25/28 , A61K31/42
Abstract: Provided herein are methods for treating multiple sclerosis using (−) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof.